Author

Santiago M. C. Lopez

h-index 2 View on Semantic Scholar

We have 3 of 19 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Modeling the public health impact of vaccination with Pfizer-BioNTech COVID-19 vaccine, LP.8.1, 2025-2026 formula in the pediatric population aged 5-17 years at high risk of severe outcomes from COVID-19 in the United States.

INTRODUCTION This study evaluated the potential public health impact of receiving Pfizer-BioNTech COVID-19 vaccine, LP.8.1, 2025-2026 formula, in the US pediatric population aged 5-17 years at high risk of severe outcomes from COVID-19. RESEARCH DESIGN AND METHODS A previously published static decision-tree model was...

A. Yehoshua, M. di Fusco, Abby E. Rudolph et al. · Expert Review of Vaccines · 0 citations

Open access Aug 2026

2024-2025 BNT162b2 KP.2 COVID-19 full season vaccine effectiveness from vaccine registries linked to administrative claims in two states: A cohort study in non-immunocompromised adults.

BNT162b2 provided protection against COVID-19-associated outcomes of ED, UC or hospitalization among non-immunocompromised U.S. adults, including those with UMCs, over the course of the 2024-2025 respiratory virus season, supporting continued vaccine recommendations.

Tara Ahi, K. Andersen, J. Mateus et al. · Vaccine · 0 citations

Jul 2026

KP.2-Adapted BNT162b2 COVID-19 Vaccine Uptake and Effectiveness in Children.

KP.2-adapted BNT162b2 COVID-19 vaccine provided significant protection against emergency department, urgent care, and inpatient encounters for COVID-19 in children.

K. Andersen, Tara Ahi, Maria D. McColgan et al. · Jornal de Pediatria · 0 citations